Literature Review: Hubungan dan Peranan Interleukin-6 (Il-6) pada Penderita COVID-19
JSN : Jurnal Sains Natural · 2023
DOI: 10.35746/jsn.v1i3.391 ↗Kurz gefasst
Fachartikel in der Zeitschrift JSN : Jurnal Sains Natural, 2023. Verfasst von Sulis Cindrayani und 3 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Coronavirus disease 2019 or better known as COVID-19 is an acute respiratory disease caused by Savere Acute Respiratory Syndrome-2 (SARS CoV-2). The purpose of this study was to determine the role and relationship of interleukin-6 (IL-6) in patients with COVID-19. The research method is a Systematic Literature Review (SLR) using electronic articles in English and Indonesian, the year the article was published starting from 2019 with a secondary research design with supporting data with the theme of the study taken, namely with the keywords: COVID-19, interleukin-6, cytokine storm in COVID-19 sufferers. In searching articles with the help of several databases. On average, the results of the 8 research articles used in this literature review show that there is a relationship and role for interleukin-6 (IL-6) in people with COVID-19. In conclusion, IL-6 has a role and relationship to sufferers of COVID-19
Zitieren
APA
Cindrayani, S., Sukmana, D. J., Hadiatun, N., & Aini, A. (2023). Literature Review: Hubungan dan Peranan Interleukin-6 (Il-6) pada Penderita COVID-19. JSN : Jurnal Sains Natural. https://doi.org/10.35746/jsn.v1i3.391
Vancouver
Cindrayani S, Sukmana DJ, Hadiatun N, Aini A. Literature Review: Hubungan dan Peranan Interleukin-6 (Il-6) pada Penderita COVID-19. JSN : Jurnal Sains Natural. 2023. doi:10.35746/jsn.v1i3.391
BibTeX
@article{Cindrayani2023,
author = {Cindrayani, Sulis and Sukmana, Dhika Juliana and Hadiatun, Nurul and Aini, Aini},
title = {Literature Review: Hubungan dan Peranan Interleukin-6 (Il-6) pada Penderita COVID-19},
journal = {JSN : Jurnal Sains Natural},
year = {2023},
doi = {10.35746/jsn.v1i3.391}
}
EUVIMED